LorenDPenaMD
Medical Genetics • Cincinnati, OHClinical Genetics
Assistant Professor, Pediatrics, Duke Univ Sch of Med
Are you Dr. Pena?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 53 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave
Cincinnati, OH 45229Phone+1 513-636-4760Fax+1 513-636-7297- Is this information wrong?
Summary
- Dr. Loren Pena, MD is a board certified medical geneticist in Cincinnati, Ohio. She is currently licensed to practice medicine in Ohio, Indiana, and Kentucky. She is affiliated with Cincinnati Children's Hospital Medical Center and Christ Hospital.
Education & Training
University of Chicago/Northwestern UniversityResidency, Medical Genetics and Genomics, 2007 - 2009- University of ChicagoResidency, Pediatrics, 2004 - 2007
Northwestern University The Feinberg School of MedicineClass of 2004
Certifications & Licensure
OH State Medical License 2018 - 2026
KY State Medical License 2021 - 2025
IN State Medical License 2021 - 2023
NC State Medical License 2012 - 2018
IL State Medical License 2004 - 2014- American Board of Pediatrics Pediatrics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Clinical Trials
- A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
- GBE Deficiency (GSD IV and APBD) Natural History Study Start of enrollment: 2015 Dec 01
- Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene Start of enrollment: 2018 Nov 27
- Join now to see all
Publications & Presentations
PubMed
- 48 citationsSafety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.Jordi Diaz-Manera, Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub, Antonio Toscano, Ans T. van der Ploeg, Kenneth I. Berger, Paula R. ...> ;The Lancet. Neurology. 2021 Dec 1
- 1 citationsCorrection: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations.Lance H Rodan, Rebecca C Spillmann, Harley T Kurata, Shawn M Lamothe, Jasmine Maghera, Rami Abou Jamra, Anna Alkelai, Stylianos E Antonarakis, Isis Atallah, Omer Bar-Y...> ;Genetics in Medicine. 2021 Oct 1
- 14 citationsPhenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations.Lance H Rodan, Rebecca C Spillmann, Harley T Kurata, Shawn M Lamothe, Jasmine Maghera, Rami Abou Jamra, Anna Alkelai, Stylianos E Antonarakis, Isis Atallah, Omer Bar-Y...> ;Genetics in Medicine. 2021 Oct 1
- Join now to see all
Press Mentions
Cyclo Therapeutics Announces Positive Efficacy Data from Extension Protocol with Trappsol® Cyclo™ in Patients with Niemann-Pick Disease Type CJanuary 5th, 2021
Sanofi Genzyme Presents Results from Phase 1/2 Study of Investigational Second-Generation Therapy for Pompe DiseaseMarch 3rd, 2016
Hospital Affiliations
Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Christ HospitalCincinnati, Ohio
